CHE Jennifer, J.D.
- Eagle IP Ltd 副總裁
Jennifer 是一名美國專利律師，對生物製藥行業有著深刻、多方面的了解。 她在為各種類型的產品、研究合作和業務發展交易推動創造性和獨特的知識產權戰略方面有著良好的記錄。在 20 年的職業生涯中，Jennifer 曾擔任過科學家、專利代理人和高管，她對如何制定既考慮到組織的技術需求又考慮到長期業務需求的知識產權策略有著深刻的認識和理解 .
Jennifer spent over ten years at Vertex Pharmaceuticals, a 40 billion USD S&P 500 pharmaceutical company, building up sophisticated global patent portfolios for the company’s UK and Canada research and development sites. Prior to joining Eagle IP, Jennifer was Vice President of IP and legal affairs at Axcella, a venture-back biotech startup focused on addressing metabolic dysregulation by leveraging amino acid biology.
Jennifer has a strong scientific foundation, from her chemistry degree at MIT to her six years working as a medicinal chemist at Takeda Oncology (formerly Millennium Pharmaceuticals). Jennifer has extensive experience in small molecules, large molecules, biotechnology, and nanotechnology-based therapeutics in a broad range of disease areas.
Jennifer 為客戶提供全球專利策略、知識產權組合管理、專利起草和申請策略、知識產權所有權等方面的建議。 她的專業領域包括化學、製藥、製劑、生物技術、醫學、藥物輸送系統和廣泛疾病領域的基於納米技術的療法。
她的工作語言是英語和普通話。